Tatsumi et al. (14) reported that the SEPT5 gene fused to MLL in an adult patient with de novo AML and also found that SEPT5 expression in AML was markedly higher than that in ALL cell lines. This evidence concerns the gene KMT2A and acute myeloid leukemia.